AVTE
Aerovate Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Timothy P. Noyes
IPO Date
2021-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Aerovate Therapeutics, Inc.
CEO
Timothy P. Noyes
IPO Date
2021-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 12,500 |
| $18.90 |
| 7 Jun 2024 | Dable Habib J | director | A-Award | Acquired | 12,500 | $18.90 |
| 7 Jun 2024 | Resnick Joshua | director | A-Award | Acquired | 12,500 | $18.90 |
| 7 Jun 2024 | GRAYZEL DAVID S. | director | A-Award | Acquired | 12,500 | $18.90 |
| 7 Jun 2024 | Iwicki Mark T | director | A-Award | Acquired | 12,500 | $18.90 |
| 7 Jun 2024 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | Acquired | 12,500 | $18.90 |
| 7 Jun 2024 | Santel Donald J | director | A-Award | Acquired | 12,500 | $18.90 |
| 17 May 2024 | NOYES TIMOTHY P | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | Disposed | 10,000 | $2.14 |
| 17 May 2024 | NOYES TIMOTHY P | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | Acquired | 10,000 | $2.14 |